|
Volumn 341, Issue 6148, 2013, Pages 853-855
|
Gene therapy that works
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRAIN;
CHILD HEALTH;
DISEASE TREATMENT;
GENE;
GENETIC ANALYSIS;
GENOTOXICITY;
IMMUNE RESPONSE;
NEUROLOGY;
BONE MARROW TRANSPLANTATION;
CELL GROWTH;
CELL PROLIFERATION;
CELL THERAPY;
GENE EXPRESSION;
GENE MUTATION;
GENE THERAPY;
GENETIC DISORDER;
HEMATOPOIETIC STEM CELL;
HOST CELL;
HUMAN;
IMMUNE DEFICIENCY;
PRIORITY JOURNAL;
SHORT SURVEY;
GENETICS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
MALE;
METABOLISM;
METACHROMATIC LEUKODYSTROPHY;
METHODOLOGY;
NOTE;
WISKOTT ALDRICH SYNDROME;
CEREBROSIDE SULFATASE;
WISKOTT ALDRICH SYNDROME PROTEIN;
CEREBROSIDE-SULFATASE;
GENETIC THERAPY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HUMANS;
LEUKODYSTROPHY, METACHROMATIC;
MALE;
WISKOTT-ALDRICH SYNDROME;
WISKOTT-ALDRICH SYNDROME PROTEIN;
|
EID: 84882776567
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1242551 Document Type: Short Survey |
Times cited : (50)
|
References (13)
|